Latest

Productivity Vs Compliance: The Balancing Act of ECM in Life Sciences

While digital transformation in life sciences starts with digitization for compliance, it should be seen as a key lever of competitive advantage and success, writes Jaleel Shujath.

China Expedites Price Reduction of Anticancer Drugs

In an attempt to reduce high drug prices and improve its medical insurance coverage, China has initiated a series of new moves, including the recent zero import tax on a range of anticancer drugs. Jin Zhang reports.

FDA Struggles to Advance Biosimilars

New Action Plan aims to streamline development, but rebates and reimbursement block market access.

The Patient-Engagement Quest: A Conversation with DIA’s Barbara Lopez Kunz

DIA’s global chief executive talks about the current trajectory of patient-centric product development and the need to establish common pathways and metrics to best harness its potential in everyday practice.

Emerging Biotech: Innovation, Location, and Inspiration

Lisa Henderson examines the rise and reach of biopharma in the key Northeast Corridor clusters of Boston, Philadelphia, and New Jersey.

Pharm Exec Video

Behind the Scenes with Kallyope’s Nancy Thornberry

A sneak peek at Pharm Exec's August cover shoot with the New York City-based biotech CEO.

Why One Korean Biotech Picked New Jersey for U.S. Headquarters

New Jersey is still a top pick for companies when it comes to pharma.

Pharm Exec Talks Partnerships with Sanofi

Hear what Sanofi looks for when they decide to form a partnership with another company.

New & Noteworthy

The Pulse of Biopharma M&A

New trends report spotlights the promise and cautions for prospective life sciences dealmakers.

‘Emerging’ Product Launch Strategies

Commercial leaders can boost product launches with a data-driven roadmap, writes Erik Cruz.

Cross-Border Funding in the Life Sciences

Record capital flows across global public and private markets has opened up new channels of investment in early-stage and novel science.

Pharm Exec’s 14th Annual Press Audit: The Opioid Crisis Takes Center Stage

The opioid crisis dominated the news in this year’s annual audit of industry press coverage.

Sales & Marketing

‘Emerging’ Product Launch Strategies

Commercial leaders can boost product launches with a data-driven roadmap, writes Erik Cruz.

Hitting Your Targets: A Check-up on Data

Provider data delivers insights into customers and drives decisions about where to focus resources, providing opportunities for sales and marketing in life sciences.

Patient Communications: Why Pharma Leaders Should Think Like Social Marketers

By exploring how social marketers think, pharma can unlock tried-and-tested ways to bring measurable value to their patients, write Patrick Ladbury and Oliver Childs.

eBooks

Emerging BioPharma: Your Guide to Clinical and Commercial Considerations

This eBook will focus on the specific needs and concerns of the smaller to mid-size biopharmaceutical company. Articles cover considerations from Phase II to commercial pathways. 

View all eBooks

PEspeaks

CEO Spills the Secret to Attracting, Retaining Biotech Talent

One of the most important jobs of a biotech executive is building a strong team that will not only keep a company competitive in the current market, but will also have the stamina to carry it into the future.

Leading Courageously and Bringing Others Along In an Evolving Healthcare Environment

To be successful, healthcare organizations must delve into optimizing leadership skills and building a deep pipeline of executive-ready talent.

Face It. You’re Not a Biotech Anymore

With increasing responsibilities and decision-making post-discovery, the traditional label of “biotech” is changing.

What Issues Are Top of Mind for Smaller Biotech and Emerging Biopharma Companies?

Daniel Patrick discusses the small biotech company journey from an incubator of ideas to the ability to shepherd an R&D asset through its pipeline to achieving commercial success.

Interviews

Navigating the Complex Reimbursement and Policy Landscape of Healthcare Access

Tommy Bramley and Kristine Flemister discuss how stakeholders can better help patients and providers navigate barriers around access and affordability in a complex healthcare environment.

The Patient-Engagement Quest: A Conversation with DIA’s Barbara Lopez Kunz

DIA’s global chief executive talks about the current trajectory of patient-centric product development and the need to establish common pathways and metrics to best harness its potential in everyday practice.

Delivering Ground-breaking Innovation to Those Who Need It

Roche's Marcus Gerund is working to bring healthcare to some of the poorest areas of the world.

Regulatory

FDA Struggles to Advance Biosimilars

New Action Plan aims to streamline development, but rebates and reimbursement block market access.

Congress, Feds, FDA Take Action in Opioid Crisis

Recent bipartisan efforts look to expand access for addiction treatment and stem inappropriate drug prescribing.

Pharma AI Requires a New Approach to Governance

Artificial intelligence adoption by pharma companies in the UK demands a new, agile governance layer, write Tim Wright and Antony Bott.

From the Editor

From Science to Success

A common thread in our exploration of "Emerging Biopharma" is that these companies need to be those that look beyond pure discovery—and put equal effort into the pivot to potential commercialization.

Blockchain 101 for Pharma Executives

With blockchain still in the potential but not proven area of the pharma enterprise, when is the technology the right choice for you?

lorem ipsum